CyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsPhosphoramide MustardsVincristineDoxorubicinAntineoplastic Agents, AlkylatingPrednisoneImmunosuppressive AgentsMethotrexatePulse Therapy, DrugDrug Administration ScheduleTreatment OutcomeEtoposideCombined Modality TherapyEpirubicinBusulfanThiotepaPrednisoloneSuperior ColliculiBreast NeoplasmsRemission InductionAntibodies, Monoclonal, Murine-DerivedVena Cava, SuperiorFluorouracilDisease-Free SurvivalBone Marrow TransplantationLeukopeniaGranulocyte Colony-Stimulating FactorVidarabineLymphoma, Non-HodgkinTransplantation, AutologousMesenteric Artery, SuperiorMethylprednisoloneDose-Response Relationship, DrugCystitisDrug Therapy, CombinationHematopoietic Stem Cell TransplantationWhole-Body IrradiationAdministration, MetronomicSurvival AnalysisChemotherapy, AdjuvantTime FactorsSurvival RateCarmustineTransplantation ConditioningMelphalanImmunosuppressionAzathioprineWegener GranulomatosisFollow-Up StudiesAntineoplastic AgentsLupus NephritisIfosfamideCisplatinMesnaRecurrenceNeutropeniaChlorambucilSuperior Vena Cava SyndromeMitoxantroneAcroleinBleomycinTransplantation, HomologousHematopoietic Stem Cell MobilizationAlkylating AgentsProcarbazineLeukocyte CountPaclitaxelDexamethasoneCytarabineAnemia, AplasticLymphoma, Large B-Cell, DiffusePrognosisProspective StudiesNeoplasm StagingCarboplatinAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisInfusions, IntravenousSuperior Cervical GanglionLeukemia, Lymphocytic, Chronic, B-CellAntibodies, MonoclonalAdministration, OralGraft vs Host DiseaseBone MarrowSpleenRetrospective StudiesVomitingMicroscopic PolyangiitisMultiple MyelomaThrombocytopeniaNeoadjuvant TherapyInjections, IntravenousDrug EvaluationTaxoidsClinical Trials as TopicNeoplasm TransplantationLymphoma, FollicularCarcinoma, Small CellMyeloablative AgonistsBiotransformation